References
- Castelino, S., Miah, H., Auyeung, V., & Vogt, F. (2015). Determination of the influence of home delivery of HIV therapy on virological outcomes and adherence. International Journal of STD & AIDS, 26(2), 93–97. https://doi.org/10.1177/0956462414530887
- Centers for Disease Control and Prevention. (2018). Continuum of Care. Updated July 23, 2018. Retrieved January 21, 2019, from https://www.cdc.gov/hiv/policies/continuum.html
- Cohen, J. (2011). Breakthrough of the year. HIV treatment as prevention. Science, 334(6063), 1628. https://doi.org/10.1126/science.334.6063.1628
- Eberhart, M. G., Yehia, B. R., Hillier, A., Voytek, C. D., Fiore, D. J., Blank, M., Frank, I., Metzger, D. S., & Brady, K. A. (2015). Individual and community factors associated with geographic clusters of poor HIV care retention and poor viral suppression. Journal of Acquired Immune Deficiency Syndromes, 69(Suppl 1), S37–S43. https://doi.org/10.1097/QAI.0000000000000587
- Gallant, J. E., DeJesus, E., Arribas, J. R., Pozniak, A. L., Gazzard, B., Campo, R. E., Lu, B., McColl, D., Chuck, S., Enejosa, J., & Toole, J. J. (2006). Tenofovir DF, emtricitabine, and efavirenz vs. zidovudine, lamivudine, and efavirenz for HIV. New England Journal of Medicine, 354(3), 251–260. https://doi.org/10.1056/NEJMoa051871
- Goswami, N. D., Schmitz, M. M., Sanchez, T., Dasgupta, S., Sullivan, P., Cooper, H., Rane, D., Kelly, J., Del Rio, C., & Waller, L. A. (2016). Understanding local spatial variation along the care continuum: The potential impact of transportation vulnerability on HIV linkage to care and viral suppression in high-poverty areas, Atlanta, Georgia. Journal of Acquired Immune Deficiency Syndromes, 72(1), 65–72. https://doi.org/10.1097/QAI.0000000000000914
- Jefferson, K. A., Kersanske, L. S., Wolfe, M. E., Braunstein, S. L., Haardörfer, R., Des Jarlais, D. C., Campbell, A. N., & Cooper, H. L. (2017). Place-based predictors of HIV viral suppression and durable suppression among men who have sex with men in New York City. AIDS and Behavior, 21(10), 2987–2999. https://doi.org/10.1007/s10461-017-1810-x
- Kalichman, S. C., Kalichman, M. O., & Cherry, C. (2017). Forget about forgetting: Structural barriers and severe non-adherence to antiretroviral therapy. AIDS Care, 29(4), 418–422. https://doi.org/10.1080/09540121.2016.1220478
- The Lancet HIV. (2017). U = U taking off in 2017. The Lancet. HIV, 4(11), e475. https://doi.org/10.1016/S2352-3018(17)30183-2
- Molina, J.-M., Podsadecki, T. J., Johnson, M. A., Wilkin, A., Domingo, P., Myers, R., Hairrell, J. M., Rode, R. A., King, M. S., & Hanna, G. J. (2007). A lopinavir/ritonavir-based once-daily regimen results in better compliance and is non-inferior to a twice-daily regimen through 96 weeks. AIDS Research and Human Retroviruses, 23(12), 1505–1514. https://doi.org/10.1089/aid.2007.0107
- Nance, R. M., Delaney, J. C., Simoni, J. M., Wilson, I. B., Mayer, K. H., Whitney, B. M., Aunon, F. M., Safren, S. A., Mugavero, M. J., Mathews, W. C., & Christopoulos, K. A. (2018). HIV viral suppression trends over time among HIV-infected patients receiving care in the United States, 1997 to 2015: A cohort study. Annals of Internal Medicine, 169(6), 376–384. https://doi.org/10.7326/M17-2242
- Parienti, J. J., Bangsberg, D. R., Verdon, R., & Gardner, E. M. (2009). Better adherence with once-daily antiretroviral regimens: A meta-analysis. Journal of Biochemistry and Molecular Biology, 48(4), 484–488. https://doi.org/10.1086/596482
- Pham, N., Lewis, S., & Avery, A. (2018). Impact of pharmacy proximity and delivery services on HIV viral suppression among low income urban patients. AIDS and Behavior, 22(3), 1025–1029. https://doi.org/10.1007/s10461-017-1823-5
- Pinoges, L., Schramm, B., Poulet, E., Balkan, S., Szumilin, E., Ferreyra, C., & Pujades-Rodriguez, M. (2015). Risk factors and mortality associated with resistance to first-line antiretroviral therapy: Multicentric cross-sectional and longitudinal analyses. Journal of Acquired Immune Deficiency Syndromes, 68(5), 527–535. https://doi.org/10.1097/QAI.0000000000000513
- Ridgway, J. P., Almirol, E. A., Schmitt, J., Schuble, T., & Schneider, J. A. (2018). Travel time to clinic but not neighborhood crime rate is associated with retention in care among HIV-positive patients. AIDS and Behavior. https://doi.org/10.1007/s10461-018-2094-5
- Schmittdiel, J. A., Karter, A. J., Dyer, W. T., Chan, J., & Duru, O. K. (2013). Safety and effectiveness of mail order pharmacy use in diabetes. The American Journal of Managed Care, 19(11), 882–887. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4278640/.
- Shubber, Z., Mills, E. J., Nachega, J. B., Vreeman, R., Freitas, M., Bock, P., Nsanzimana, S., Penazzato, M., Appolo, T., Doherty, M., & Ford, N. (2016). Patient-Reported barriers to adherence to antiretroviral therapy: A systematic review and meta-analysis. PLoS Medicine, 13(11), e1002183. https://doi.org/10.1371/journal.pmed.1002183
- U.S. Census Bureau. (2016). Community facts. https://factfinder.census.gov/faces/nav/jsf/pages/community_facts.xhtml?src=bkmk
- van Sighem, A. I., van de Wiel, M. A., Ghani, A. C., Jambroes, M., Reiss, P., Gyssens, I. C., Brinkman, K., Lange, J. M., de Wolf, F., & ATHENA Cohort Study Group. (2003). Mortality and progression to AIDS after starting highly active antiretroviral therapy. AIDS, 17(15), 2227–2236. https://doi.org/10.1097/01.aids.0000088199.77946.17 doi: 10.1097/00002030-200310170-00011
- Yehia, B. R., Fleishman, J. A., Metlay, J. P., Moore, R. D., & Gebo, K. A. (2012). Sustained viral suppression in HIV-infected patients receiving antiretroviral therapy. JAMA, 308(4), 339–342. https://doi.org/10.1001/jama.2012.5927